Nivolumab + ipilimumab (NIVO + IPI) adjuvant versus placebo dans le carcinome rénal localisé à haut risque de récidive après néphrectomie : résultats de l’étude de phase 3 randomisée Checkmate 914 (CM914)
2022-01-01 Barthélémy, P.; Motzer, R.; Russo, P.; Grünwald, V.; Tomita, Y.; Zurawski, B.; Parikh, O.; Buti, S.; Goh, J.; Ye, D.; Lingua, A.; Lattouf, J.; Escudier, B.; George, S.; Shuch, B.; Simsek, B.; Spiridigliozzi, J.; Chudnovsky, A.; Bex, A.
112 Circulating and molecular markers of inflammation: impact on treatment response and survival among older patients with cancer treated with immune checkpoint inhibitors
2022-01-01 Choucair, Khalil; Nebhan, Caroline; Cortellini, Alessio; Hentzen, Stijn; Wang, Yinghong; Salama, April; Elliott, Andrew; Oberley, Matthew; Walker, Phillip; Bokhari, Raza; Giusti, Raffaele; Filetti, Marco; Ascierto, Paolo; Vannella, Vito; Galetta, Domenico; Catino, Annamaria; Pizzutilo, Pamela; Genova, Carlo; Bersanelli, Melissa; Buti, Sebastiano; Saeed, Azhaar; El-Deiry, Wafik; Beltran, Himisha; Nabhan, Chadi; Johnson, Douglas; Fulgenzi, Claudia; Pinato, David; Radford, Maluki; Liu, Stephen; Kim, Chul; Naqash, Rafeh; Saeed, Anwaar
91 Circulating lipid profile as a prognostic factor in patients with advanced solid tumors treated with immune checkpoint inhibitors
2022-01-01 Pecci, Federica; Cantini, Luca; Cognigni, Valeria; Perrone, Fabiana; Agostinelli, Veronica; Mazzaschi, Giulia; Favari, Elda; Maffezzoli, Michele; Cortellini, Alessio; Rossi, Francesca; Chiariotti, Rebecca; Venanzi, Francesco; Mentrasti, Giulia; Russo, Giuseppe Lo; Galli, Giulia; Proto, Claudia; Ganzinelli, Monica; Tronconi, Francesca; Morgese, Francesca; Campolucci, Carla; Moretti, Marco; Vignini, Arianna; Bersanelli, Melissa; Buti, Sebastiano; Berardi, Rossana
238P Exploring blood immune cell dynamics to unravel the immunomodulatory effect of radiotherapy in NSCLC patients undergoing immune checkpoint inhibitors
2022-01-01 Mazzaschi, G.; Tamarozzi, P.; Lorusso, B.; Verzè, M.; Pluchino, M.; Trentini, F.; Dalla Valle, B.; Minari, R.; Perrone, F.; Bordi, P.; Leonetti, A.; Moron Dalla Tor, L.; Leo, L.; Milanese, G.; Balbi, M.; Buti, S.; Roti, G.; Quaini, F.; Sverzellati, N.; Tiseo, M.
The circulation of Edward Gibbon’s books in Eighteen century Lombardy
2021-01-01 Bono, Francesco
The protection of imperial statues in Late Antiquity
2021-01-01 Bono, Francesco
Contemporary challenges and alternatives to international criminal justice: an introduction to the VIII AIDP Symposium for Young Penalists
2022-01-01 Barbosa, Renata; Mazzacuva, Francesco; Ochi, Megumi
THE ROLE OF BLOOD CHOLESTEROL QUALITY IN PATIENTS WITH ADVANCED CANCER RECEIVING IMMUNE CHECKPOINT INHIBITORS
2022-01-01 Matilde, C.; Perrone, F.; Favari, E.; Maglietta, G.; Verzè, M.; Pluchino, M.; Minari, R.; Sabato, R.; Mazzaschi, G.; Cortellini, A.; Pecci, F.; Cantini, L.; Bersanelli, M.; Tiseo, M.; Buti, S.
CLINICAL OUTCOME OF PATIENTS WITH NON-CLEAR METASTATIC RENAL CELL CARCINOMA TREATED WITH PEMBROLIZUMAB-AXITINIB COMBINATION. NEMESIA (NON CLEAR METASTATIC RENAL CELL CARCINOMA PEMBROLIZUMAB AXITINIB) STUDY, A SUBGROUP ANALYSIS OF I-RARE OBSERVATIONAL STUDY (MEET-URO 23A)
2022-01-01 Stellato, M.; Buti, S.; Maruzzo, M.; Bersanelli, M.; Ermacora, P.; Maiorano, B. A.; Prati, V.; De Giorgi, U.; Pierantoni, F.; Malgeri, A.; Mennitto, A.; Cavo, A.; Vitale, M. G.; Santoni, M.; Carella, C.; Procopio, G.; Verzoni, E.; Santini, D.
IMMUNE TUMOR MICROENVIRONMENT (I-TME) ANALYSES IN METASTATIC RENAL CELL CARCINOMA (MRCC) PATIENTS (PTS) TREATED WITH SECOND LINE NIVOLUMAB: RESULTS FROM THE MEET-URO 18 STUDY
2022-01-01 Rebuzzi, S. E.; Rescigno, P.; Signori, A.; Brunelli, M.; Galuppini, F.; Vellone, V. G.; Gaggero, G.; Maruzzo, M.; Milella, M.; Vignani, F.; Cavo, A.; Basso, U.; Gandini, A.; Puglisi, S.; Borea, R.; Martelli, V.; Llaja Obispo, M. A.; Banna, G. L.; Buti, S.; Fornarini, G.
LONGITUDINAL MONITORING OF RADIOMIC AND BLOOD IMMUNE-INFLAMMATORY DESCRIPTORS AS A NON-INVASIVE APPROACH TO PREDICT ICI EFFICACY IN ADVANCED NSCLC PATIENTS
2022-01-01 Mazzaschi, G; Moron Dalla Tor, L; Balbi, M; Milanese, G; Leo, L; Dalla Valle, B; Trentini, F; Lorusso, B; Verzè, M; Pluchino, M; Minari, R; Perrone, F; Bordi, P; Leonetti, A; Buti, S; Silva, M; Roti, G; Sverzellati, N; Quaini, F; Tiseo, M
FIRST LINE AVELUMAB IN PD-L1+VE METASTATIC OR LOCALLY ADVANCED UROTHELIAL CANCER (AUC) PATIENTS UNFIT FOR CISPLATIN (CIS): THE ARIES TRIAL
2022-01-01 Ciccarese, C; Brunelli, M; Battelli, N; Buttigliero, C; Caserta, C; Buti, S; Santini, D; Naglieri, E; Galli, L; Verri, E; Ermacora, P; Milella, M; Masini, C; Aprile, G; Milesi, L; Spina, F; Rizzo, M; Sperduti, I; Fornarini, G; Iacovelli, R
PREBIOTIC EFFECT OF A FORMULA SUPPLEMENTED WITH GALACTO-OLIGOSACCHARIDES IN TERM INFANTS: A RANDOMIZED MULTICENTER TRIAL
2013-01-01 M., Giovannini; E., Verduci; G., Zuccotti; Biasucci, G; A., Podestà; A., Rottoli; D., Gregori; S., Ballali; S., Soldi; G., Banderali; D., Ghisleni; E., Riva
The hidden pandemic: COVID-19-related stress, SLC6A4 methylation, and infants' temperament at 3 months
2021-01-01 L., Provenzi; F., Mambretti; M., Villa; S., Grumi; A., Citterio; E., Bertazzoli; Biasucci, G; L., Decembrino; R., Falcone; B., Gardella; R., Longo; R., Nacinovich; C., Pisoni; F., Prefumo; S., Orcesi; B., Scelsa; R., Giorda; R., Borgatti
LBA4 Adjuvant nivolumab plus ipilimumab (NIVO+IPI) vs placebo (PBO) for localized renal cell carcinoma (RCC) at high risk of relapse after nephrectomy: Results from the randomized, phase III CheckMate 914 trial
2022-01-01 Motzer, R. J.; Russo, P.; Gruenwald, V.; Tomita, Y.; Zurawski, B.; Parikh, O. A.; Buti, S.; Barthelemy, P.; Goh, J. C. H.; Ye, D.; Lingua, A.; Lattouf, J-B.; Escudier, B.; George, S.; B. Shuch, Null; Simsek, B.; Spiridigliozzi, J.; Chudnovsky, A.; Bex, A.
1476P Immunohistochemical (mIHC) analyses of the immune tumor microenvironment (I-TME) in metastatic renal cell carcinoma (mRCC) patients (pts) receiving immunotherapy: Main results from the Meet-URO 18 study
2022-01-01 Rebuzzi, S. E.; Rescigno, P.; Signori, A.; Brunelli, M.; Galuppini, F.; Vellone, V. G.; Gaggero, G.; Maruzzo, M.; Milella, M.; Vignani, F.; Cavo, A.; Basso, U.; Catalano, F.; Murianni, V.; Cremante, M.; Damassi, A.; Llaja Obispo, M. A.; Banna, G. L.; Buti, S.; Fornarini, G.
1462P Clinical outcome of patients with non-clear metastatic renal cell carcinoma treated with pembrolizumab-axitinib combination: NEMESIA (non-clear metastatic renal cell carcinoma pembrolizumab axitinib) study, a subgroup analysis of I-RARE observational study (Meet-URO 23a)
2022-01-01 Stellato, M.; Buti, S.; Maruzzo, M.; Bersanelli, M.; Ermacora, P.; Maiorano, B. A.; Prati, V.; De Giorgi, U. F. F.; Pierantoni, F.; Malgeri, A.; Mennitto, A.; Cavo, A.; Vitale, M. G.; Santoni, M.; Carella, C.; Procopio, G.; Verzoni, E.; Santini, D.
Dynamic evolution of blood immune-inflammatory descriptors in advanced non-small cell lung cancer undergoing first-line immunotherapy-based regimens
2022-01-01 Mazzaschi, G; Verze, M; Tognazzi, D; Lorusso, B; Minari, R; Pluchino, M; Trentini, F; Manini, M; Bordi, P; Leonetti, A; Perrone, F; Coriano, M; Casali, M; Toscani, I; Cosenza, A; Ferri, L; Buti, S; Sverzellati, N; Quaini, F; Tiseo, M
P1.15-04 Dynamic Profiling of Blood Immunophenotypes and Radiomic Features to Predict Immunotherapy Response in Advanced Non-small Cell Lung Cancer
2022-01-01 Mazzaschi, G.; Moron Dalla Tor, L.; Milanese, G.; Balbi, M.; Tognazzi, D.; Lorusso, B.; Verzè, M.; Pluchino, M.; Minari, R.; Leo, L.; Ledda, R. E.; Bordi, P.; Leonetti, A.; Buti, S.; Roti, G.; Quaini, F.; Sverzellati, N.; Tiseo, M.
Presentazione
2021-01-01 Cavallo, Jo Ann; Confalonieri, Corrado
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Nivolumab + ipilimumab (NIVO + IPI) adjuvant versus placebo dans le carcinome rénal localisé à haut risque de récidive après néphrectomie : résultats de l’étude de phase 3 randomisée Checkmate 914 (CM914) | 1-gen-2022 | Barthélémy, P.; Motzer, R.; Russo, P.; Grünwald, V.; Tomita, Y.; Zurawski, B.; Parikh, O.; Buti, S.; Goh, J.; Ye, D.; Lingua, A.; Lattouf, J.; Escudier, B.; George, S.; Shuch, B.; Simsek, B.; Spiridigliozzi, J.; Chudnovsky, A.; Bex, A. | |
| 112 Circulating and molecular markers of inflammation: impact on treatment response and survival among older patients with cancer treated with immune checkpoint inhibitors | 1-gen-2022 | Choucair, Khalil; Nebhan, Caroline; Cortellini, Alessio; Hentzen, Stijn; Wang, Yinghong; Salama, April; Elliott, Andrew; Oberley, Matthew; Walker, Phillip; Bokhari, Raza; Giusti, Raffaele; Filetti, Marco; Ascierto, Paolo; Vannella, Vito; Galetta, Domenico; Catino, Annamaria; Pizzutilo, Pamela; Genova, Carlo; Bersanelli, Melissa; Buti, Sebastiano; Saeed, Azhaar; El-Deiry, Wafik; Beltran, Himisha; Nabhan, Chadi; Johnson, Douglas; Fulgenzi, Claudia; Pinato, David; Radford, Maluki; Liu, Stephen; Kim, Chul; Naqash, Rafeh; Saeed, Anwaar | |
| 91 Circulating lipid profile as a prognostic factor in patients with advanced solid tumors treated with immune checkpoint inhibitors | 1-gen-2022 | Pecci, Federica; Cantini, Luca; Cognigni, Valeria; Perrone, Fabiana; Agostinelli, Veronica; Mazzaschi, Giulia; Favari, Elda; Maffezzoli, Michele; Cortellini, Alessio; Rossi, Francesca; Chiariotti, Rebecca; Venanzi, Francesco; Mentrasti, Giulia; Russo, Giuseppe Lo; Galli, Giulia; Proto, Claudia; Ganzinelli, Monica; Tronconi, Francesca; Morgese, Francesca; Campolucci, Carla; Moretti, Marco; Vignini, Arianna; Bersanelli, Melissa; Buti, Sebastiano; Berardi, Rossana | |
| 238P Exploring blood immune cell dynamics to unravel the immunomodulatory effect of radiotherapy in NSCLC patients undergoing immune checkpoint inhibitors | 1-gen-2022 | Mazzaschi, G.; Tamarozzi, P.; Lorusso, B.; Verzè, M.; Pluchino, M.; Trentini, F.; Dalla Valle, B.; Minari, R.; Perrone, F.; Bordi, P.; Leonetti, A.; Moron Dalla Tor, L.; Leo, L.; Milanese, G.; Balbi, M.; Buti, S.; Roti, G.; Quaini, F.; Sverzellati, N.; Tiseo, M. | |
| The circulation of Edward Gibbon’s books in Eighteen century Lombardy | 1-gen-2021 | Bono, Francesco | |
| The protection of imperial statues in Late Antiquity | 1-gen-2021 | Bono, Francesco | |
| Contemporary challenges and alternatives to international criminal justice: an introduction to the VIII AIDP Symposium for Young Penalists | 1-gen-2022 | Barbosa, Renata; Mazzacuva, Francesco; Ochi, Megumi | |
| THE ROLE OF BLOOD CHOLESTEROL QUALITY IN PATIENTS WITH ADVANCED CANCER RECEIVING IMMUNE CHECKPOINT INHIBITORS | 1-gen-2022 | Matilde, C.; Perrone, F.; Favari, E.; Maglietta, G.; Verzè, M.; Pluchino, M.; Minari, R.; Sabato, R.; Mazzaschi, G.; Cortellini, A.; Pecci, F.; Cantini, L.; Bersanelli, M.; Tiseo, M.; Buti, S. | |
| CLINICAL OUTCOME OF PATIENTS WITH NON-CLEAR METASTATIC RENAL CELL CARCINOMA TREATED WITH PEMBROLIZUMAB-AXITINIB COMBINATION. NEMESIA (NON CLEAR METASTATIC RENAL CELL CARCINOMA PEMBROLIZUMAB AXITINIB) STUDY, A SUBGROUP ANALYSIS OF I-RARE OBSERVATIONAL STUDY (MEET-URO 23A) | 1-gen-2022 | Stellato, M.; Buti, S.; Maruzzo, M.; Bersanelli, M.; Ermacora, P.; Maiorano, B. A.; Prati, V.; De Giorgi, U.; Pierantoni, F.; Malgeri, A.; Mennitto, A.; Cavo, A.; Vitale, M. G.; Santoni, M.; Carella, C.; Procopio, G.; Verzoni, E.; Santini, D. | |
| IMMUNE TUMOR MICROENVIRONMENT (I-TME) ANALYSES IN METASTATIC RENAL CELL CARCINOMA (MRCC) PATIENTS (PTS) TREATED WITH SECOND LINE NIVOLUMAB: RESULTS FROM THE MEET-URO 18 STUDY | 1-gen-2022 | Rebuzzi, S. E.; Rescigno, P.; Signori, A.; Brunelli, M.; Galuppini, F.; Vellone, V. G.; Gaggero, G.; Maruzzo, M.; Milella, M.; Vignani, F.; Cavo, A.; Basso, U.; Gandini, A.; Puglisi, S.; Borea, R.; Martelli, V.; Llaja Obispo, M. A.; Banna, G. L.; Buti, S.; Fornarini, G. | |
| LONGITUDINAL MONITORING OF RADIOMIC AND BLOOD IMMUNE-INFLAMMATORY DESCRIPTORS AS A NON-INVASIVE APPROACH TO PREDICT ICI EFFICACY IN ADVANCED NSCLC PATIENTS | 1-gen-2022 | Mazzaschi, G; Moron Dalla Tor, L; Balbi, M; Milanese, G; Leo, L; Dalla Valle, B; Trentini, F; Lorusso, B; Verzè, M; Pluchino, M; Minari, R; Perrone, F; Bordi, P; Leonetti, A; Buti, S; Silva, M; Roti, G; Sverzellati, N; Quaini, F; Tiseo, M | |
| FIRST LINE AVELUMAB IN PD-L1+VE METASTATIC OR LOCALLY ADVANCED UROTHELIAL CANCER (AUC) PATIENTS UNFIT FOR CISPLATIN (CIS): THE ARIES TRIAL | 1-gen-2022 | Ciccarese, C; Brunelli, M; Battelli, N; Buttigliero, C; Caserta, C; Buti, S; Santini, D; Naglieri, E; Galli, L; Verri, E; Ermacora, P; Milella, M; Masini, C; Aprile, G; Milesi, L; Spina, F; Rizzo, M; Sperduti, I; Fornarini, G; Iacovelli, R | |
| PREBIOTIC EFFECT OF A FORMULA SUPPLEMENTED WITH GALACTO-OLIGOSACCHARIDES IN TERM INFANTS: A RANDOMIZED MULTICENTER TRIAL | 1-gen-2013 | M., Giovannini; E., Verduci; G., Zuccotti; Biasucci, G; A., Podestà; A., Rottoli; D., Gregori; S., Ballali; S., Soldi; G., Banderali; D., Ghisleni; E., Riva | |
| The hidden pandemic: COVID-19-related stress, SLC6A4 methylation, and infants' temperament at 3 months | 1-gen-2021 | L., Provenzi; F., Mambretti; M., Villa; S., Grumi; A., Citterio; E., Bertazzoli; Biasucci, G; L., Decembrino; R., Falcone; B., Gardella; R., Longo; R., Nacinovich; C., Pisoni; F., Prefumo; S., Orcesi; B., Scelsa; R., Giorda; R., Borgatti | |
| LBA4 Adjuvant nivolumab plus ipilimumab (NIVO+IPI) vs placebo (PBO) for localized renal cell carcinoma (RCC) at high risk of relapse after nephrectomy: Results from the randomized, phase III CheckMate 914 trial | 1-gen-2022 | Motzer, R. J.; Russo, P.; Gruenwald, V.; Tomita, Y.; Zurawski, B.; Parikh, O. A.; Buti, S.; Barthelemy, P.; Goh, J. C. H.; Ye, D.; Lingua, A.; Lattouf, J-B.; Escudier, B.; George, S.; B. Shuch, Null; Simsek, B.; Spiridigliozzi, J.; Chudnovsky, A.; Bex, A. | |
| 1476P Immunohistochemical (mIHC) analyses of the immune tumor microenvironment (I-TME) in metastatic renal cell carcinoma (mRCC) patients (pts) receiving immunotherapy: Main results from the Meet-URO 18 study | 1-gen-2022 | Rebuzzi, S. E.; Rescigno, P.; Signori, A.; Brunelli, M.; Galuppini, F.; Vellone, V. G.; Gaggero, G.; Maruzzo, M.; Milella, M.; Vignani, F.; Cavo, A.; Basso, U.; Catalano, F.; Murianni, V.; Cremante, M.; Damassi, A.; Llaja Obispo, M. A.; Banna, G. L.; Buti, S.; Fornarini, G. | |
| 1462P Clinical outcome of patients with non-clear metastatic renal cell carcinoma treated with pembrolizumab-axitinib combination: NEMESIA (non-clear metastatic renal cell carcinoma pembrolizumab axitinib) study, a subgroup analysis of I-RARE observational study (Meet-URO 23a) | 1-gen-2022 | Stellato, M.; Buti, S.; Maruzzo, M.; Bersanelli, M.; Ermacora, P.; Maiorano, B. A.; Prati, V.; De Giorgi, U. F. F.; Pierantoni, F.; Malgeri, A.; Mennitto, A.; Cavo, A.; Vitale, M. G.; Santoni, M.; Carella, C.; Procopio, G.; Verzoni, E.; Santini, D. | |
| Dynamic evolution of blood immune-inflammatory descriptors in advanced non-small cell lung cancer undergoing first-line immunotherapy-based regimens | 1-gen-2022 | Mazzaschi, G; Verze, M; Tognazzi, D; Lorusso, B; Minari, R; Pluchino, M; Trentini, F; Manini, M; Bordi, P; Leonetti, A; Perrone, F; Coriano, M; Casali, M; Toscani, I; Cosenza, A; Ferri, L; Buti, S; Sverzellati, N; Quaini, F; Tiseo, M | |
| P1.15-04 Dynamic Profiling of Blood Immunophenotypes and Radiomic Features to Predict Immunotherapy Response in Advanced Non-small Cell Lung Cancer | 1-gen-2022 | Mazzaschi, G.; Moron Dalla Tor, L.; Milanese, G.; Balbi, M.; Tognazzi, D.; Lorusso, B.; Verzè, M.; Pluchino, M.; Minari, R.; Leo, L.; Ledda, R. E.; Bordi, P.; Leonetti, A.; Buti, S.; Roti, G.; Quaini, F.; Sverzellati, N.; Tiseo, M. | |
| Presentazione | 1-gen-2021 | Cavallo, Jo Ann; Confalonieri, Corrado |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Articolo su rivista1767
Data di pubblicazione
- 2020 - 2025192
- 2010 - 2019832
- 2000 - 2009517
- 1990 - 1999174
- 1980 - 198951
- 1979 - 19791
Editore
- ELSEVIER25
- SAGE PUBLICATIONS LTD17
- DIKE GIURIDICA15
- Elsevier13
- ASCO pubs11
- ELSEVIER IRELAND LTD7
- ASCO6
- ELSEVIER SCIENCE INC5
- SAGE5
- SPRINGERNATURE4
Rivista
- DIGESTIVE AND LIVER DISEASE101
- GASTROENTEROLOGY100
- ANNALS OF ONCOLOGY93
- BLOOD89
- JOURNAL OF CLINICAL ONCOLOGY58
- HAEMATOLOGICA56
- NEUROLOGICAL SCIENCES47
- UNITED EUROPEAN GASTROENTEROLOGY ...46
- ANNALS OF THE RHEUMATIC DISEASES36
- REUMATISMO26
Keyword
- Helicobacter pylori10
- sclerosi sistemica6
- Bioengineering5
- Gastroenterology5
- HCV5
- UV5
- GERD4
- Lungs4
- anodal stimulation3
- beat-to-beat variability of cardi...3
Lingua
- eng926
- ita177
- fre1
Accesso al fulltext
- no fulltext1735
- reserved26
- open6